NGM Biopharmaceuticals Inc (NASDAQ:NGM)

Delayed Data
As of Nov 25
 +0.045 / +0.84%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for NGM Biopharmaceuticals Inc have a median target of 5.00, with a high estimate of 9.00 and a low estimate of 4.00. The median estimate represents a -6.98% decrease from the last price of 5.38.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Hold stock in NGM Biopharmaceuticals Inc. This rating has held steady since October, when it was downgraded from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 12.71%
Growthannually -35.04%


Growthquarterly -14.50%
Growthannually -43.56%
Key to the earnings and sales forecast charts.